Drawing for MEDDA

USPTO serial 97098431

MEDDA

Reviewed by CopyMark Law Group

Filing date
Status date
Registration date
—
Examiner
ARRISON, RACHEL MARIE
Law office
TMEG LAW OFFICE 106 - EXAMINING ATTORNEY ASSIGNED

What this means

These status codes mean the trademark application is abandoned and no longer pending. Common reasons include missing an Office Action response (600), filing without a valid basis (602), express abandonment by the applicant (604), or failure to respond to an examiner's inquiry (618). Revival may be possible in limited circumstances. If abandonment was unintentional, consult counsel about a petition to revive. Otherwise file a new application if protection is still needed.

Status 602: These status codes mean the trademark application is abandoned and no longer pending. Common reasons include missing an Office Action response (600), filing without a valid basis (602), express abandonment by the applicant (604), or failure to respond to an examiner's inquiry (618). Revival may be possible in limited circumstances.

Need help with MEDDA?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Michael B. Dodd

Michael B. Dodd DODD LAW GROUP2742 ST. MARY'S WAYSALT LAKE CITY, UT 84108UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
009Downloadable mobile application for aggregating health data and information and tracking progress of health outcomes or other data and information that reflects relative levels of clinical or economic benefits in patient care; Downloadable mobile application for remote gathering and aggregating of health data and information from wireless, IoT, 5G, and other wirelessly enabled digital health devices and wearable devices; Downloadable mobile application for scanning digital two dimensional codes for purposes of analyzing quantitative data pertaining to consumable product compositions; Wearable computers; Downloadable computer software and programs for collecting, processing, analyzing, transmitting, validating and displaying data in the medical, scientific and pharmaceutical fields; Downloadable computer software for the monitoring of health data, medical data, genetic data, movement data, nutritional data, wellness data, geographic data, health risk data, and demographic data for use with medical clinical trials; Downloadable computer software for data processing and analysis for use with medical clinical trials; Downloadable computer software for managing clinical trials; Downloadable computer software for managing chronic health conditions; Downloadable computer software used to improve health outcomes by managing patient treatments, compliance, and results; Downloadable computer software for logging dates and times for the purpose of managing dietary supplement intake; Downloadable computer software for logging dates and times for the purpose of managing cannabinoid intake; Downloadable computer software for enabling purchasing of natural therapeutics by connecting patients to authorized pharmacies; Downloadable computer software for clinical trial data collection, storage and analysis; Data processing equipment, namely, couplers; Recorded computer software for controlling surgical equipment; Downloadable computer software and downloadable computer programs for transmission of medical and scientific data and information; Downloadable educational media, namely, indicate form of goods, e.g., audio files, video recordings, multimedia files, etc. featuring information in the medical, scientific and pharmaceutical fields; downloadable software for providing an on-line database of health care information; downloadable software for capturing and analyzing health care data to improve patient care; non-downloadable software recorded on computer media capturing and analyzing health care data to improve patient care; Downloadable computer software applications and mobile applications using artificial intelligence for tailoring pharmaceutical formulation compositions, medical recommendations, holistic health recommendations, and therapeutic product purchasing; Downloadable computer communications software for enabling and facilitating remote participation in clinical research, therapy, telehealth, drug research and development, and monitoring real world evidence of drug and therapeutic safety and efficacy; Downloadable mobile applications using artificial intelligence for use in delivering precision medicine by collecting medical data, physiological data, and behavioral patterns of patients for use in formulating digital therapeutics (DTx), and for delivering digital therapeutics (DTx) to said patients; Downloadable mobile applications using artificial intelligence for formulating precision and tailored doses of bioactive substances via wirelessly enabled smart delivery devices; Downloadable mobile applications using artificial intelligence for controlling wireless technologies existing on wirelessly enabled devices in order to transfer information to said devices in order to deliver prescriptions for drugs and therapeutic substances; Downloadable mobile applications using artificial intelligence for use in communicating clinical research, data, information, and recommendations to patients, consumers, practitioners, clinical researchers, and regulatory organizations; Downloadable software applications for gathering data and information to obtain and analyze information about consumer health and preferences; Downloadable software applications for providing instructions to users on how to employ health-improving activities in the nature of exercise and lifestyle changes; Downloadable software applications for gathering data and information to obtain and analyze information for purposes of matching individuals to therapeutics based on known and hypothesized ethnobotanical data and research; Downloadable software for collecting data on a patient's use of and subjective experience with nutritional supplements; Downloadable software for providing information to guide patients on use of nutritional supplements; Downloadable software for monitoring and tracking data to improve the efficacy of nutritional supplements; Downloadable software for monitoring and tracking data to improve the side effects of nutritional supplements; Downloadable software for collecting biometric data from patients; Downloadable machine learning software for analyzing data and analyzing semantics from customer review data, IoT and wearable devices, biometric devices, biomedical devices, genomics records, and electronic health records; Downloadable machine learning software for analyzing consumer behavior, health metrics, mental health data, clinical trial and research data, therapeutic product performance research data, and pharmaceutical and botanical drug research and development data; Downloadable mobile applications using artificial intelligence and natural language processing (NLP) for analyzing semantic feedback, structured and unstructured health records data, social media posts and conversation records, for purposes of identifying, analyzing, treating, calculating, and providing health data and information to patients, customers, researchers, clinicians, and companies; Downloadable computer chatbot software for simulating conversations; Downloadable conversational agent software for simulating conversations; Downloadable computer chatbot software using artificial intelligence for use by individuals to have brief daily conversations to help measure and improve their moods and learn about themselves; Downloadable mobile applications using artificial intelligence for use by individuals to have brief daily conversations to help measure and improve their moods and learn about health and wellness; Downloadable mobile applications for enabling communications over the internet to facilitate interactions with medical and holistic health practitioners on the subjects of health and wellness; Downloadable computer application software for mobile devices, namely, for enabling communications for individuals to have brief daily conversations to help measure and improve their health metrics and moods and learn about conditions and symptoms; Downloadable mobile applications using artificial intelligence for use matching individuals to therapeutic substances; Downloadable mobile applications using artificial intelligence for use in gathering data regarding health metrics, records, and information via IoT, 5G, and other wireless means; Downloadable mobile applications using artificial intelligence for use in controlling, and gathering and monitoring data and information from wearable devices, biometric devices, and digital health applications; Downloadable mobile applications using artificial intelligence for use by individuals to provide health information in the field of health and wellness, behavioral health, and mental health; Downloadable virtual reality communications computer software for enabling and facilitating remote participation in clinical research, therapy, telehealth, drug research and development, and monitoring real world evidence of drug and therapeutic safety and efficacy; Downloadable virtual reality software for providing explain what digital therapeutic is; Downloadable computer software for providing explain what digital therapeutic is; Downloadable virtual reality software for enabling access to virtual e-commerce marketplaces; Downloadable computer software for specify the function of the software, e.g., use as a spreadsheet, word processing, etc. in the fields of healthcare, therapeutics, pharmaceuticals, and nutritional supplements; Downloadable computer software for monitoring, reporting on, and analyzing the use of therapeutics, pharmaceuticals, and nutritional supplements; Downloadable communications software for enabling healthcare providers and patients to communicate regarding healthcare and the use of therapeutics, pharmaceuticals, and nutritional supplements; Downloadable software applications and mobile applications for aggregating health data and tracking progress of health outcomes and other data that reflects relative levels of clinical or economic benefits in patient care; Downloadable software for analyzing data and validating technology solutions by evaluating their usability, adoptability, quality, accuracy, functional benefits, and impact on clinical and economic outcomes in the fields of healthcare, technologies development, drug research and development, clinical research, medical practitioning, healthcare information technology, and holistic healthcareACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

Latest event (MAB2): The trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time.

DateCodeEventWhat it means
Apr 3, 2023MAB2ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPONDThe trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time.
Apr 3, 2023MAB2ABANDONMENT NOTICE MAILED - FAILURE TO RESPONDThe trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time.
Apr 3, 2023ABN2ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSEThe trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time.
Sep 19, 2022GNFNNOTIFICATION OF FINAL REFUSAL EMAILED—
Sep 19, 2022GNFRFINAL REFUSAL E-MAILEDA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Sep 19, 2022CNFRFINAL REFUSAL WRITTENA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Aug 22, 2022DOCKASSIGNED TO EXAMINER—
Aug 19, 2022TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Aug 18, 2022CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Aug 18, 2022TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Feb 18, 2022GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Feb 18, 2022GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Feb 18, 2022CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jan 26, 2022DOCKASSIGNED TO EXAMINER—
Nov 10, 2021NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Nov 1, 2021NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance